A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatment.

MLA

Kaiser, Jesko, et al. “A Novel Binding Site in the Nicotinic Acetylcholine Receptor for MB327 Can Explain Its Allosteric Modulation Relevant for Organophosphorus-Poisoning Treatment.” Toxicology Letters, vol. 373, Jan. 2023, pp. 160–71. EBSCOhost, https://doi.org/10.1016/j.toxlet.2022.11.018.

APA

Kaiser, J., Gertzen, C. G. W., Bernauer, T., Höfner, G., Niessen, K. V., Seeger, T., Paintner, F. F., Wanner, K. T., Worek, F., Thiermann, H., & Gohlke, H. (2023). A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatment. Toxicology Letters, 373, 160–171. https://doi.org/10.1016/j.toxlet.2022.11.018

Chicago

Kaiser, Jesko, Christoph G W Gertzen, Tamara Bernauer, Georg Höfner, Karin V Niessen, Thomas Seeger, Franz F Paintner, et al. 2023. “A Novel Binding Site in the Nicotinic Acetylcholine Receptor for MB327 Can Explain Its Allosteric Modulation Relevant for Organophosphorus-Poisoning Treatment.” Toxicology Letters 373 (January): 160–71. doi:10.1016/j.toxlet.2022.11.018.